Stock Market & Financial Investment News

News Breaks February 8, 2013 17:13 EDT NEO, ABT Abbott reports 7.73% passive stake in NeoGenomics News For ABT;NEO From The Last 14 Days Check below for free stories on ABT;NEO the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 21, 2013 08:03 EDT ABT Abbott announces CE Mark for coronary drug eluting stent Subscribe for More Information May 20, 2013 10:11 EDT ABT On The Fly: Analyst Upgrade Summary Subscribe for More Information 06:01 EDT ABT Abbott upgraded to Buy from Neutral at Goldman Goldman upgraded Abbott to reflect accelerating growth driven by emerging markets, better growth and product mix, new product launches, and market share gains. Price target raised to $44 from $38. May 9, 2013 07:04 EDT ABT Abbott announces CE Mark for A1c test Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.